Search Results for keywords:"drug discovery"

The National Institutes of Health (NIH) announced a closed meeting for the Center for Scientific Review Special Emphasis Panel, focusing on drug discovery for neurodevelopmental disorders. This meeting is scheduled for January 10, 2025, from 10:00 a.m. to 5:00 p.m., and will take place virtually. The meeting will be private to protect confidential information and trade secrets related to the grant applications under discussion. Dr. Lai Yee Leung is the contact person for the event, and she can be reached at the NIH in Bethesda, Maryland.

The Center for Scientific Review (CSR) of the National Institutes of Health (NIH) is conducting a series of virtual closed meetings to assess grant applications. These meetings, which will occur from March 31 to April 25, 2025, are focused on various scientific disciplines, including neuroscience, drug discovery, and infectious diseases. The meetings are closed to the public as they involve discussions on confidential information, such as trade secrets and personal details. More information about each committee and their respective contact persons is provided in the notice.

The document announces several closed meetings of the Center for Scientific Review at the National Institutes of Health. These meetings, scheduled to occur between March 10 and March 16, 2021, will not be open to the public due to the confidential nature of information, such as trade secrets and personal privacy, that will be discussed. Various committees are set to review and evaluate grant applications on topics ranging from Alzheimer's Disease clinical trials to biostatistical methods, disease prevention, and drug discovery. The meetings will be conducted virtually, and the contact information for Scientific Review Officers handling these meetings is provided.

The National Institutes of Health (NIH) will hold several closed meetings to review and evaluate grant applications. These meetings, organized by the Center for Scientific Review, are scheduled to take place from February 24 to March 2, 2021, and will be conducted as virtual meetings. The meetings cover a wide range of scientific topics, including biobehavioral processes, brain disorders, genetic research, cancer studies, healthcare methodologies, and drug discovery. The sessions are closed to ensure the confidentiality of trade secrets or personal information.

In accordance with the Federal Advisory Committee Act, the National Institutes of Health (NIH) announced that several meetings of the Center for Scientific Review will be held virtually. These meetings, taking place between March 19 and March 24, 2021, are closed to the public due to the sensitive nature of the discussions, which include evaluating grant applications and potential disclosure of confidential materials. The subject matter of the meetings ranges from drug discovery and neurodegenerative disorders to HIV/AIDS prevention and treatment, with various scientific review officers assigned to manage the sessions. These sessions aim to review and evaluate various grant proposals, ensuring that personal privacy and proprietary information remain protected.